Factors Influencing Delay in Diagnosis of Head and Neck Cancer in Rwanda.
delays in care
global health
head and neck cancer
health equity
Journal
The Laryngoscope
ISSN: 1531-4995
Titre abrégé: Laryngoscope
Pays: United States
ID NLM: 8607378
Informations de publication
Date de publication:
Apr 2024
Apr 2024
Historique:
revised:
13
09
2023
received:
22
05
2023
accepted:
27
09
2023
medline:
18
3
2024
pubmed:
17
10
2023
entrez:
17
10
2023
Statut:
ppublish
Résumé
Head and neck cancer is a significant contributor to global otolaryngologic disease burden, with a disproportionate impact on low- and middle-income countries. This study investigates the factors contributing to delays in head and neck cancer diagnosis at the University Teaching Hospital of Kigali (CHUK). Cross-sectional study of all patients with a pathologic diagnosis of head and neck cancer presenting to CHUK between January 2021 and June 2022. Sociodemographic data, tumor characteristics, and reasons for delay were collected. Univariate and multivariable analyses were undertaken to evaluate risk factors for delays. Eighty-one patients met criteria for inclusion. Median duration from patient first reported symptoms to initial medical consultation was 52 weeks, from initial medical consultation to referral to CHUK was 4 weeks, and from referral to final pathologic diagnosis was 6 weeks. The most common reason for delay to referral to CHUK was financial (37.04%). Patients who visited traditional healers had higher odds of delay between symptom onset and medical consultation (OR 3.51, CI 1.05-11.70). Delays in final diagnosis after referral were most commonly due to OR availability for biopsy (37.04%) and time for pathology results after biopsy (35.80%). OR availability had a significant impact on duration to final diagnosis (OR 59.48, CI 7.17-493.67). Stage 4 disease had the shortest time to final diagnosis (OR 0.05, CI 0.01-0.45). Understanding the reasons for delayed diagnosis of head and neck cancer may help guide improvements in care, with the goal of reducing global head and neck burden of disease. 3; prospective non-random follow-up study Laryngoscope, 134:1663-1669, 2024.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1663-1669Informations de copyright
© 2023 The American Laryngological, Rhinological and Otological Society, Inc.
Références
Kocarnik JM, Compton K, Dean FE, et al. Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis for the global burden of disease study 2019. JAMA Oncol. 2022;8(3):420-444. https://doi.org/10.1001/jamaoncol.2021.6987.
World malaria report 2020. World Health Organization. 2020 https://www.who.int/publications/i/item/9789240015791.
GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the global burden of disease study 2016. Lancet. 2017;390(10100):1211-1259. https://doi.org/10.1016/s0140-6736(17)32154-2.
Gupta B, Johnson NW, Kumar N. Global epidemiology of head and neck cancers: a continuing challenge. Oncology. 2016;91(1):13-23. https://doi.org/10.1159/000446117.
Joshi P, Dutta S, Chaturvedi P, Nair S. Head and neck cancers in developing countries. Rambam Maimonides Med J. 2014;5(2):e0009. https://doi.org/10.5041/rmmj.10143.
Fagan JJ. Africa: a window on challenges and opportunities for head and neck cancer. Laryngoscope Investig Otolaryngol. 2021;6(3):414-419. https://doi.org/10.1002/lio2.554.
Patterson RH, Fischman VG, Wasserman I, et al. Global burden of head and neck cancer: economic consequences, health, and the role of surgery. Otolaryngol Head Neck Surg. 2020;162(3):296-303. https://doi.org/10.1177/0194599819897265.
Sylla BS, Wild CP. A million africans a year dying from cancer by 2030: what can cancer research and control offer to the continent? Int J Cancer. 2012;130(2):245-250. https://doi.org/10.1002/ijc.26333.
World Health Organization. WHO report on cancer: setting priorities, investing wisely and providing care for all. Accessed February 18, 2021 https://www.who.int/publications-detail-redirect/who-report-on-cancer-setting-priorities-investing-wisely-and-providing-care-for-all.
World Bank. World Bank Data Help Desk: World Bank country and lending groups. Accessed August 16, 2022 https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups.
Ngwa W, Addai BW, Adewole I, et al. Cancer in sub-Saharan Africa: a lancet oncology commission. Lancet Oncol. 2022;23(6):e251-e312. https://doi.org/10.1016/s1470-2045(21)00720-8.
Alexis H. The challenges and examination of new Programme Ubudehe 2020 in Rwanda. Am J Ind Bus Manag. 2023;13:287-311. https://doi.org/10.4236/ajibm.2023.135019.
Krishnatreya M, Kataki AC, Sharma JD, et al. Educational levels and delays in start of treatment for head and neck cancers in north-East India. Asian Pac J Cancer Prev. 2014;15(24):10867-10869. https://doi.org/10.7314/apjcp.2014.15.24.10867.
Nieminen M, Atula T, Bäck L, Mäkitie A, Jouhi L, Aro K. Factors influencing patient and health care delays in oropharyngeal cancer. J Otolaryngol Head Neck Surg. 2020;49(1):22. https://doi.org/10.1186/s40463-020-00413-w.
Lee SC, Tang IP, Avatar SP, et al. Head and neck cancer: possible causes for delay in diagnosis and treatment. Med J Malaysia. 2011;66(2):101-104.
Kassirian S, Dzioba A, Hamel S, et al. Delay in diagnosis of patients with head-and-neck cancer in Canada: impact of patient and provider delay. Curr Oncol. 2020;27(5):e467-e477. https://doi.org/10.3747/co.27.6547.
Friedrich RE. Delay in diagnosis and referral patterns of 646 patients with oral and maxillofacial cancer: a report from a single institution in Hamburg, Germany. Anticancer Res. 2010;30(5):1833-1836.
Felippu AW, Freire EC, Silva Rde A, Guimarães AV, Dedivitis RA. Impact of delay in the diagnosis and treatment of head and neck cancer. Braz J Otorhinolaryngol. 2016;82(2):140-143. https://doi.org/10.1016/j.bjorl.2015.10.009.
Kerdpon D, Sriplung H. Factors related to delay in diagnosis of oral squamous cell carcinoma in southern Thailand. Oral Oncol. 2001;37(2):127-131. https://doi.org/10.1016/s1368-8375(00)00072-5.
Lee JJ, Dhepnorrarat C, Nyhof-Young J, Witterick I. Investigating patient and physician delays in the diagnosis of head and neck cancers: a Canadian perspective. J Cancer Educ. 2016;31(1):8-14. https://doi.org/10.1007/s13187-014-0777-9.
Kerdpon D, Jantharapattana K, Sriplung H. Factors related to diagnostic delay of oral squamous cell carcinoma in southern Thailand: revisited. Oral Dis. 2018;24(3):347-354. https://doi.org/10.1111/odi.12757.
Shaye DA, Nakarmi KK, Shakya P, et al. Mobile surgical scouts increase surgical access for patients with cleft lip and palate in Nepal. Facial Plast Surg Aesthet Med. 2022;24(6):447-452. https://doi.org/10.1089/fpsam.2021.0117.
Baratti-Mayer D, Baba Daou M, Gayet-Ageron A, Jeannot E, Pittet-Cuénod B. Sociodemographic characteristics of traditional healers and their knowledge of Noma: a descriptive survey in three regions of Mali. Int J Environ Res Public Health. 2019;16(22):4587. https://doi.org/10.3390/ijerph16224587.
Farley E, Bala HM, Lenglet A, et al. I treat it but I don't know what this disease is': a qualitative study on Noma (cancrum oris) and traditional healing in Northwest Nigeria. Int Health. 2020;12(1):28-35. https://doi.org/10.1093/inthealth/ihz066.
Chirwa GC, Suhrcke M, Moreno-Serra R. Socioeconomic inequality in premiums for a community-based health insurance scheme in Rwanda. Health Policy Plan. 2021;36(1):14-25. https://doi.org/10.1093/heapol/czaa135.
Nyandekwe M, Nzayirambaho M, Kakoma JB. Universal health insurance in Rwanda: major challenges and solutions for financial sustainability case study of Rwanda community-based health insurance part I. Pan Afr Med J. 2020;37:55. https://doi.org/10.11604/pamj.2020.37.55.20376.
Barasa E, Kazungu J, Nguhiu P, Ravishankar N. Examining the level and inequality in health insurance coverage in 36 sub-Saharan African countries. BMJ Glob Health. 2021;6(4):e004712. https://doi.org/10.1136/bmjgh-2020-004712.
Stanford-Moore GB, Niyigaba G, Tuyishimire G, et al. Effect of delay of care for patients with craniomaxillofacial trauma in Rwanda. OTO Open. 2022;6(2):2473974X221096032. https://doi.org/10.1177/2473974X221096032.
Fagan JJ, Otiti J, Aswani J, et al. African head and neck fellowships: a model for a sustainable impact on head and neck cancer care in developing countries. Head Neck. 2019;41(6):1824-1829. https://doi.org/10.1002/hed.25615.
Mulwafu W, Ensink R, Kuper H, Fagan J. Survey of ENT services in sub-Saharan Africa: little progress between 2009 and 2015. Glob Health Action. 2017;10(1):1289736. https://doi.org/10.1080/16549716.2017.1289736.
Cancedda C, Cotton P, Shema J, et al. Health professional training and capacity strengthening through international academic partnerships: the first five years of the human resources for health program in Rwanda. Int J Health Policy Manag. 2018;7(11):1024-1039. https://doi.org/10.15171/ijhpm.2018.61.